A survey of current evaluation and treatment of gout

Naomi Schlesinger, Dirk Moore, Jennifer D. Sun, H. Ralph Schumacher

Research output: Contribution to journalReview article

47 Citations (Scopus)

Abstract

Objective. To record diagnostic and treatment approaches to gouty arthritis among US rheumatologists. Methods. Questionnaires were faxed to 2500 US rheumatologists. Results. Responses were received from 518 rheumatologists. Respondents reported performing crystal analysis 80% of the time for new suspected gout; 64% use combination therapy for acute gout; non-steroidal antiinflammatory drugs alone are used in only 27%. Urate-lowering drugs (ULD) are given to most patients. ULD treatment is given occasionally to patients with asymptomatic hyperuricemia (4%) but most frequently to patients after 2 (59%) or 3 (34%) attacks. ULD are given with the aim of achieving a serum urate (SU) level of 6 mg/dl. Conclusion. Combination antiinflammatory agents are used frequently for acute gout despite absence of evidence in the literature to support this practice. There seems to be consensus regarding the necessity of lowering SU to < 6 mg/dl. Approaches vary widely, supporting the need for longterm prospective, placebo controlled studies to provide more evidence-based guidance.

Original languageEnglish (US)
Pages (from-to)2050-2052
Number of pages3
JournalJournal of Rheumatology
Volume33
Issue number10
StatePublished - Oct 1 2006

Fingerprint

Gout
Uric Acid
Pharmaceutical Preparations
Anti-Inflammatory Agents
Gouty Arthritis
Therapeutics
Hyperuricemia
Serum
Placebos
Surveys and Questionnaires
Rheumatologists

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Keywords

  • Gout
  • Survey
  • Treatment

Cite this

Schlesinger, Naomi ; Moore, Dirk ; Sun, Jennifer D. ; Schumacher, H. Ralph. / A survey of current evaluation and treatment of gout. In: Journal of Rheumatology. 2006 ; Vol. 33, No. 10. pp. 2050-2052.
@article{b1d6866e395e4d9abc9122f1cd3071d0,
title = "A survey of current evaluation and treatment of gout",
abstract = "Objective. To record diagnostic and treatment approaches to gouty arthritis among US rheumatologists. Methods. Questionnaires were faxed to 2500 US rheumatologists. Results. Responses were received from 518 rheumatologists. Respondents reported performing crystal analysis 80{\%} of the time for new suspected gout; 64{\%} use combination therapy for acute gout; non-steroidal antiinflammatory drugs alone are used in only 27{\%}. Urate-lowering drugs (ULD) are given to most patients. ULD treatment is given occasionally to patients with asymptomatic hyperuricemia (4{\%}) but most frequently to patients after 2 (59{\%}) or 3 (34{\%}) attacks. ULD are given with the aim of achieving a serum urate (SU) level of 6 mg/dl. Conclusion. Combination antiinflammatory agents are used frequently for acute gout despite absence of evidence in the literature to support this practice. There seems to be consensus regarding the necessity of lowering SU to < 6 mg/dl. Approaches vary widely, supporting the need for longterm prospective, placebo controlled studies to provide more evidence-based guidance.",
keywords = "Gout, Survey, Treatment",
author = "Naomi Schlesinger and Dirk Moore and Sun, {Jennifer D.} and Schumacher, {H. Ralph}",
year = "2006",
month = "10",
day = "1",
language = "English (US)",
volume = "33",
pages = "2050--2052",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "10",

}

Schlesinger, N, Moore, D, Sun, JD & Schumacher, HR 2006, 'A survey of current evaluation and treatment of gout', Journal of Rheumatology, vol. 33, no. 10, pp. 2050-2052.

A survey of current evaluation and treatment of gout. / Schlesinger, Naomi; Moore, Dirk; Sun, Jennifer D.; Schumacher, H. Ralph.

In: Journal of Rheumatology, Vol. 33, No. 10, 01.10.2006, p. 2050-2052.

Research output: Contribution to journalReview article

TY - JOUR

T1 - A survey of current evaluation and treatment of gout

AU - Schlesinger, Naomi

AU - Moore, Dirk

AU - Sun, Jennifer D.

AU - Schumacher, H. Ralph

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Objective. To record diagnostic and treatment approaches to gouty arthritis among US rheumatologists. Methods. Questionnaires were faxed to 2500 US rheumatologists. Results. Responses were received from 518 rheumatologists. Respondents reported performing crystal analysis 80% of the time for new suspected gout; 64% use combination therapy for acute gout; non-steroidal antiinflammatory drugs alone are used in only 27%. Urate-lowering drugs (ULD) are given to most patients. ULD treatment is given occasionally to patients with asymptomatic hyperuricemia (4%) but most frequently to patients after 2 (59%) or 3 (34%) attacks. ULD are given with the aim of achieving a serum urate (SU) level of 6 mg/dl. Conclusion. Combination antiinflammatory agents are used frequently for acute gout despite absence of evidence in the literature to support this practice. There seems to be consensus regarding the necessity of lowering SU to < 6 mg/dl. Approaches vary widely, supporting the need for longterm prospective, placebo controlled studies to provide more evidence-based guidance.

AB - Objective. To record diagnostic and treatment approaches to gouty arthritis among US rheumatologists. Methods. Questionnaires were faxed to 2500 US rheumatologists. Results. Responses were received from 518 rheumatologists. Respondents reported performing crystal analysis 80% of the time for new suspected gout; 64% use combination therapy for acute gout; non-steroidal antiinflammatory drugs alone are used in only 27%. Urate-lowering drugs (ULD) are given to most patients. ULD treatment is given occasionally to patients with asymptomatic hyperuricemia (4%) but most frequently to patients after 2 (59%) or 3 (34%) attacks. ULD are given with the aim of achieving a serum urate (SU) level of 6 mg/dl. Conclusion. Combination antiinflammatory agents are used frequently for acute gout despite absence of evidence in the literature to support this practice. There seems to be consensus regarding the necessity of lowering SU to < 6 mg/dl. Approaches vary widely, supporting the need for longterm prospective, placebo controlled studies to provide more evidence-based guidance.

KW - Gout

KW - Survey

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33750034285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750034285&partnerID=8YFLogxK

M3 - Review article

C2 - 17014020

AN - SCOPUS:33750034285

VL - 33

SP - 2050

EP - 2052

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 10

ER -